Literature DB >> 23973767

Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver.

Abraham J Kandathil1, Frederik Graw, Jeffrey Quinn, Hyon S Hwang, Michael Torbenson, Alan S Perelson, Stuart C Ray, David L Thomas, Ruy M Ribeiro, Ashwin Balagopal.   

Abstract

BACKGROUND & AIMS: Hepatitis C virus (HCV) predominantly infects hepatocytes, but many hepatocytes are not infected; studies have shown that HCV antigens cluster within the liver. We investigated spatial distribution and determinants of HCV replication in human liver samples.
METHODS: We analyzed liver samples from 4 patients with chronic HCV infection (genotype 1, Metavir scores 0-1) to estimate the proportion of infected hepatocytes and the amount of HCV viral RNA (vRNA) per cell. Single-cell laser capture microdissection was used to capture more than 1000 hepatocytes in grids, to preserve geometric relationships. HCV vRNA and interferon-induced transmembrane protein 3 (IFITM3) messenger RNA (the transcript of an interferon-stimulated gene) were measured in the same hepatocytes by quantitative polymerase chain reaction and assembled in maps to identify areas of high and low HCV replication.
RESULTS: Patients' serum levels of HCV RNA ranged from 6.87 to 7.40 log10 IU/mL; the proportion of HCV-infected hepatocytes per person ranged from 21% to 45%, and the level of vRNA ranged from 1 to 50 IU/hepatocyte. Infection was not random; we identified clustering of HCV-positive hepatocytes using infected-neighbor analysis (P < .0005) and distance to the kth nearest neighbor compared with random distributions, obtained by bootstrap simulations (P < .02). Hepatocytes that expressed IFITM3 did not appear to cluster and were largely HCV negative.
CONCLUSIONS: We used single-cell laser capture and high-resolution analysis to show that in human liver HCV infects hepatocytes in nonrandom clusters, whereas expression of antiviral molecules is scattered among hepatocytes. These findings show that quantitative single-cell RNA measurements can be used to estimate the abundance of HCV vRNA per infected human hepatocyte and are consistent with cell-cell propagation of infection in the absence of clustered IFITM3.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AIDS Linked to Intravenous Experience; ALIVE; HCV; HIV; IFITM3; ISG; Intrahepatic Infection; LCM; PCR; Virology; cDNA; complementary DNA; hepatitis C virus; human immunodeficiency virus; interferon-induced transmembrane protein 3; interferon-stimulated gene; laser-capture microdissection; mRNA; messenger RNA; polymerase chain reaction; qPCR; quantitative polymerase chain reaction; scLCM; single-cell laser-capture microdissection; vRNA; viral RNA

Mesh:

Substances:

Year:  2013        PMID: 23973767      PMCID: PMC4005338          DOI: 10.1053/j.gastro.2013.08.034

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line.

Authors:  L Yao; H Dong; H Zhu; D Nelson; C Liu; L Lambiase; X Li
Journal:  J Viral Hepat       Date:  2011-03-16       Impact factor: 3.728

2.  Severity and correlates of liver disease in hepatitis C virus-infected injection drug users.

Authors:  Rudra Rai; Lucy E Wilson; Jacquie Astemborski; Frank Anania; Michael Torbenson; Charles Spoler; David Vlahov; Steffanie A Strathdee; John Boitnott; Kenrad E Nelson; David L Thomas
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

3.  Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users.

Authors:  Supriya Munshaw; Hyon S Hwang; Michael Torbenson; Jeffrey Quinn; Kasper D Hansen; Jacquie Astemborski; Shruti H Mehta; Stuart C Ray; David L Thomas; Ashwin Balagopal
Journal:  Hepatology       Date:  2012-07-06       Impact factor: 17.425

4.  Visualizing hepatitis C virus infections in human liver by two-photon microscopy.

Authors:  Yuqiong Liang; Tuya Shilagard; Shu-Yuan Xiao; Ned Snyder; Daryl Lau; Luca Cicalese; Heidi Weiss; Gracie Vargas; Stanley M Lemon
Journal:  Gastroenterology       Date:  2009-07-24       Impact factor: 22.682

5.  Human 7SL RNA consists of a 140 nucleotide middle-repetitive sequence inserted in an alu sequence.

Authors:  E Ullu; S Murphy; M Melli
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

6.  Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C.

Authors:  J M Barrera; M Bruguera; M G Ercilla; C Gil; R Celis; M P Gil; M del Valle Onorato; J Rodés; A Ordinas
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

7.  Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity.

Authors:  Marlène Dreux; Urtzi Garaigorta; Bryan Boyd; Elodie Décembre; Josan Chung; Christina Whitten-Bauer; Stefan Wieland; Francis V Chisari
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

8.  Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.

Authors:  Kimberly A Dowd; Dale M Netski; Xiao-Hong Wang; Andrea L Cox; Stuart C Ray
Journal:  Gastroenterology       Date:  2009-03-17       Impact factor: 22.682

9.  Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission.

Authors:  Claire L Brimacombe; Joe Grove; Luke W Meredith; Ke Hu; Andrew J Syder; Maria Victoria Flores; Jennifer M Timpe; Sophie E Krieger; Thomas F Baumert; Timothy L Tellinghuisen; Flossie Wong-Staal; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

10.  IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.

Authors:  Eric M Feeley; Jennifer S Sims; Sinu P John; Christopher R Chin; Thomas Pertel; Li-Mei Chen; Gaurav D Gaiha; Bethany J Ryan; Ruben O Donis; Stephen J Elledge; Abraham L Brass
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

View more
  51 in total

Review 1.  How do persistent infections with hepatitis C virus cause liver cancer?

Authors:  Jonathan K Mitchell; Stanley M Lemon; David R McGivern
Journal:  Curr Opin Virol       Date:  2015-09-29       Impact factor: 7.090

Review 2.  Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.

Authors:  Jacinta A Holmes; Ming-Lung Yu; Raymond T Chung
Journal:  Expert Opin Drug Saf       Date:  2017-05-19       Impact factor: 4.250

3.  Editorial Commentary: Another Call to Cure Hepatitis B.

Authors:  Ashwin Balagopal; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2015-06-16       Impact factor: 9.079

4.  Acute hepatitis B virus infection in humanized chimeric mice has multiphasic viral kinetics.

Authors:  Yuji Ishida; Tje Lin Chung; Michio Imamura; Nobuhiko Hiraga; Suranjana Sen; Hiroshi Yokomichi; Chise Tateno; Laetitia Canini; Alan S Perelson; Susan L Uprichard; Harel Dahari; Kazuaki Chayama
Journal:  Hepatology       Date:  2018-06-06       Impact factor: 17.425

5.  Hepatitis C virus RNA functionally sequesters miR-122.

Authors:  Joseph M Luna; Troels K H Scheel; Tal Danino; Katharina S Shaw; Aldo Mele; John J Fak; Eiko Nishiuchi; Constantin N Takacs; Maria Teresa Catanese; Ype P de Jong; Ira M Jacobson; Charles M Rice; Robert B Darnell
Journal:  Cell       Date:  2015-03-12       Impact factor: 41.582

6.  Diagnostic accuracy of intracellular uptake rates calculated using dynamic Gd-EOB-DTPA-enhanced MRI for hepatic fibrosis stage.

Authors:  Krishna Juluru; Andrew H Talal; Rhonda K Yantiss; Pascal Spincemaille; Elizabeth K Weidman; Ashley E Giambrone; Sadaf Jalili; Steven P Sourbron; Jonathan P Dyke
Journal:  J Magn Reson Imaging       Date:  2016-08-16       Impact factor: 4.813

Review 7.  The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA.

Authors:  You Li; Daisuke Yamane; Takahiro Masaki; Stanley M Lemon
Journal:  Nat Rev Microbiol       Date:  2015-08-10       Impact factor: 60.633

Review 8.  Viral kinetic modeling: state of the art.

Authors:  Laetitia Canini; Alan S Perelson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-06-25       Impact factor: 2.745

9.  Single Hepatocyte Hepatitis B Virus Transcriptional Landscape in HIV Coinfection.

Authors:  Ashwin Balagopal; Hyon S Hwang; Tanner Grudda; Jeffrey Quinn; Richard K Sterling; Mark S Sulkowski; Chloe L Thio
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

Review 10.  Modeling Viral Spread.

Authors:  Frederik Graw; Alan S Perelson
Journal:  Annu Rev Virol       Date:  2016-08-31       Impact factor: 10.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.